13. Multiple sclerosis/Neuromyelitis optica
3,050 clinical trials,   2,147 drugs   (DrugBank: 348 drugs),   244 drug target genes,   228 drug target pathways

Searched query = "Multiple sclerosis/Neuromyelitis optica", "Multiple sclerosis", "Neuromyelitis optica", "MS", "NMOSD", "Devic disease", "Balo concentric sclerosis", "Baló concentric sclerosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2004-003761-33-ES
(EUCTR)
17/02/200525/01/2006Unicenter double-blind, cross-over, randomised, placebo controlled clinical trial to evaluate efficacy of vardenafil in subjects with E.D. and multiple sclerosis (M.S.) - EMDEUnicenter double-blind, cross-over, randomised, placebo controlled clinical trial to evaluate efficacy of vardenafil in subjects with E.D. and multiple sclerosis (M.S.) - EMDE Erectile DysfunctionTrade Name: Levitra
Product Name: Vardenafil (hidrocloride)
INN or Proposed INN: VARDENAFILO HIDROCLORURO
Trade Name: Levitra
Product Name: Vardenafil (hidrocloride)
INN or Proposed INN: VARDENAFILO HIDROCLORURO
Trade Name: Levitra
Product Name: Vardenafil (hidrocloride)
INN or Proposed INN: VARDENAFILO HIDROCLORURO
Unidad de NeuroinmunologíaNULLAuthorised-recruitment may be ongoing or finishedFemale:
Male: yes
28Spain